Placebo group (n = 75) | Amiodarone group (n = 75) | P value | |
---|---|---|---|
Age (years) | 57.31 ± 6.85 | 57.76 ± 5.80 | 0.663 |
Gender | |||
Male | 45 (60%) | 42 (56%) | 0.62 |
Female | 30 (40%) | 33 (44%) | |
Hypertension | 38 (50.7%) | 34 (45.3%) | 0.513 |
DM | 34 (45.3%) | 45 (60%) | 0.072 |
Smoking | 21 (28%) | 19 (25.3%) | 0.712 |
CCS > 3 | 53 (70.7%) | 47 (62.7%) | 0.299 |
NYHA > III | 26 (34.7%) | 24 (32%) | 0.729 |
Previous MI | 25 (33.3%) | 24 (32%) | 0.862 |
Obesity | 9 (12%) | 7 (9.3%) | 0.597 |
Preoperative EF (%) | 49.63 ± 5.68 | 51.03 ± 6.53 | 0.163 |
Preoperative LA size (%) | 3.68 ± 0.32 | 3.73 ± 0.29 | 0.317 |
Operative data | |||
Ischemic time (min) | 61.19 ± 9.5 | 63.85 ± 8.16 | 0.067 |
Total bypass time (min) | 97.59 ± 9.77 | 95.89 ± 8.47 | 0.259 |
Intraoperative inotropes | 48 (64%) | 46 (61.3%) | 0.736 |
Number of grafts | 2.60 ± 1.15 | 2.32 ± 0.82 | 0.089 |